Henry Schein (HSIC) stock is in focus after the company secured exclusive U.S. distribution rights for CytoChip’s FDA-cleared CitoCBC system, the first cartridge-based CBC device with a CLIA Waiver ...
West Bengal seems to have forgotten its profound spiritual legacy from which sprung its fierce nationalistic instincts.